Hi Guest
X
Real-Time Quote
Enter Company or MFGlaxoSmithKline Pharmaceuticals Ltd. - Research Center
Results |
Half yearly
|
Statement | |
More |
Half yearly results in brief
| Jun ' 09 | Dec ' 08 | Jun ' 08 | Dec ' 07 | Jun ' 07 | |
|---|---|---|---|---|---|
| Sales | 922.93 | 792.30 | 888.38 | 689.24 | 887.90 |
| Operating profit | 335.81 | 294.64 | 303.32 | 270.15 | 267.35 |
| Interest | -45.60 | -70.02 | - | - | - |
| Gross profit | 399.41 | 332.92 | 363.32 | 301.58 | 325.76 |
| EPS (Rs) | 31.60 | 40.19 | 27.88 | 38.95 | 24.53 |
Annual results in details
| Jun ' 09 | Dec ' 08 | Jun ' 08 | Dec ' 07 | Jun ' 07 | |
|---|---|---|---|---|---|
| Other income | 18.00 | -31.74 | 60.00 | 31.43 | 58.41 |
| Stock adjustment | 1.03 | -8.03 | 5.70 | 17.78 | 14.95 |
| Raw material | 185.23 | 175.51 | 176.36 | 12.28 | 309.24 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 96.36 | 86.95 | 85.80 | 68.88 | 82.38 |
| Excise | -2.01 | -55.43 | 50.55 | -69.26 | 76.10 |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 306.51 | 298.66 | 266.65 | 389.41 | 137.88 |
| Provisions made | - | - | - | - | - |
| Depreciation | 7.63 | 8.73 | 7.61 | 8.78 | 7.38 |
| Taxation | 134.69 | 111.96 | 119.58 | 100.83 | 110.63 |
| Net profit / loss | 267.62 | 340.44 | 236.13 | 329.91 | 207.75 |
| Extra ordinary item | 10.53 | 128.21 | - | 137.94 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 84.70 | 84.70 | 84.70 | 84.70 | 84.70 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 417.86 | 417.86 | 417.86 | 417.86 | 417.86 |
| Agg.of non promotoholding (%) | 49.30 | 49.30 | 49.30 | 49.30 | 49.30 |
| OPM (%) | 36.39 | 37.19 | 34.14 | 39.20 | 30.11 |
| GPM (%) | 42.45 | 43.77 | 38.31 | 41.85 | 34.42 |
| NPM (%) | 28.44 | 44.76 | 24.90 | 45.78 | 21.95 |